National News
India puts restrictions on Platinum alloy imports

India has announced restrictions on imports of unwrought platinum and platinum powder, with an exception for alloys containing at least 99% pure platinum, according to a government notification issued on Wednesday.
The Directorate General of Foreign Trade (DGFT) revised the import policy for platinum, moving certain categories from the “free” list to the “restricted” list.
Under the new policy, imports of unwrought platinum, platinum powder, and other specified forms require authorization from the DGFT, except for platinum alloys that have a purity of 99% or more by weight.
To ensure a steady supply for jewelry and industrial uses, the government has allowed the unrestricted import of platinum alloys with a purity of at least 99%.
This change comes in response to concerns that some importers were taking advantage of tariff differences by blending gold with platinum to bypass higher import duties on gold.
The economic think tank GTRI had earlier raised concerns about the duty-free imports of gold, silver, platinum, and diamonds from the UAE, cautioning that the arrangement could be exploited to avoid tariffs.
In October of the previous year, India voiced concerns over the rising imports of silver products, platinum alloys, and dry dates from the UAE, calling for stricter enforcement of the rules of origin under the Free Trade Agreement (FTA). Following discussions, the UAE agreed to address India’s concerns.

National News
Shree Ramkrishna Exports Launches “Kriam Pharma”
Kriam Pharma to Target Key Therapeutic Segments with Direct-to-Chemist Model; Backed by Gates Foundation for South Africa Supply, Aims Pan-India Reach by 2030 and Over 3,500 Jobs

Shree Ramkrishna Exports (SRK), a leader in the natural diamond industry,has forayed into healthcare with the launch of “Kriam Pharma.” The inauguration ceremony, held in Surat under the theme “Aarogyam: A New Flight towards Health & Healing”, marked the official unveiling of this new venture.
The launch event was graced by dignitaries including Surat Mayor Daksheshbhai Mavani, SRK Founder & Chairman Govindbhai Dholakia, Dr Vijay Agarwal, President, Consortium of Accredited Healthcare Organizations (CAHO), Dr Giridhar Gyani, Director General, Association of Healthcare Providers of India (AHPI), Mathurbhai Savani, Chairman of Kiran Hospital, Arnav Kapoor, Deputy Director of Bill & Melinda Gates Foundation, Padma Shri Savjibhai Dholakia of Hari Krishna Exports and several leaders from the healthcare ecosystem.

Speaking on the occasion, Tej Dholakia, Founder of Kriam Pharma said, “Healthcare is a necessity for everyone, yet access to quality medicines at affordable prices remains a challenge. With Kriam Pharma, we aim to bridge this gap by delivering high-quality medicines while building trust between providers and patients. This is not merely a business journey, but a journey of service. We will ensure quality medicines at fair prices, initially reaching 20,000 towns and villages.”
Kriam Pharma will focus on categories such as anti-diabetic, cardiac care, gastrointestinal, pain management, dermatology, vitamins and minerals and anti-infectives, covering both immediate and long-term healthcare needs. In a highly fragmented market, the company will deliver reliability, while adhering to the highest ethical standards.
Mayor Daksheshbhai Mavani congratulated SRK on the new venture and expressed hope that with support from the Bill & Melinda Gates Foundation, Kriam Pharma would supply its medicines even to South Africa. He said, “The company would initially focus on Gujarat and Maharashtra, adopting a direct-to-chemist distribution model for efficiency and trust.”


CAHO President Dr. Vijay Agarwal said, “Even though remarkable progress has been made in medicine over the last 100 years, trust deficit remains. He stressed the importance of accessible and affordable care and wished success to Kriam Pharma in bridging gaps with quality medicines.”
Kriam Pharma aims to supply medicines across every city, town and village in India by 2030, while creating more than 3,500 direct and indirect jobs. The company is also exploring exports to emerging markets with high demand for dependable and high-quality medicines.
AHPI Director General Dr. Giridhar Gyani said, “30% of the hospital expenditure is on medicines, which highlights the need for affordable, accessible and quality medicines.”

Kriam Pharma is currently sourcing its products from leading Contract Development and Manufacturing Organizations (CDMOs) and plans to set up in-house manufacturing in the second phase.
Reaffirming the company’s mission, Tej Dholakia added, “Our mission is rooted in a simple belief that medicine is not a privilege, it is a basic right. Every product, every partnership and every decision we make reflects our commitment to quality and integrity.”

Shreyans Dholakia, Brand Custodian of SRK Exports said, “With 60 years of excellence in natural diamonds, we are now committed to serving the nation in healthcare. Healthcare is a key focus area of the country.”
Govindbhai Dholakia, Founder- Chairman Emeritus of SRK Group said, “A company may be precious, but it must also be valuable. With Kriam Pharma, let us ensure that we uphold values alongside value, making this venture truly meaningful.”

-
National News2 weeks ago
GST on gold, silver jewellery remains unchanged at 3%, with additional 5% on making charges
-
ShowBuzz11 hours ago
Jos Alukkas hosts Signature Jewellery Show in Hyderabad
-
International News9 hours ago
PGI Initiatives at Jewellery and Gem WORLD Hong Kong Spotlight Platinum as Priority Metal for Brighter Future
-
BrandBuzz11 hours ago
Indriya unveils ‘Devi’, a Navaratri Collection celebrating the Divine Feminine